End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
39.9 CNY | +0.50% |
|
-3.53% | -11.78% |
06-18 | Hengrui Pharmaceuticals, Subsidiary Get Regulatory Nod to Test Two Drugs | MT |
06-05 | Hengrui Pharma Units Get China Nod for Clinical Trial of Tumor Drug | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-11.78% | 34.92B | |
+54.61% | 811B | |
+43.90% | 640B | |
-6.33% | 353B | |
+20.62% | 333B | |
+10.44% | 302B | |
+18.04% | 246B | |
+2.54% | 225B | |
+12.76% | 218B | |
+8.61% | 168B |
- Stock Market
- Equities
- 600276 Stock
- News Jiangsu Hengrui Medicine Co., Ltd.
- Hengrui Pharmaceuticals, Subsidiary Get Regulatory Nod to Test Two Drugs